Skip to main content

Advertisement

Log in

Soy isoflavones attenuate bone loss in early postmenopausal Chinese women

A single-blind randomized, placebo-controlled trial

  • ORIGINAL CONTRIBUTION
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Background

Previous studies show that daily doses of 40–99 mg soy isoflavones produce inconsistent effects on preventing estrogen-related bone loss in postmenopausal women.

Aim of the study

To examined the bone-sparing effect of isoflavones at a higher dose in early Chinese postmenopausal women.

Methods

A total of 90 eligible women aged 45–60 years were randomly assigned to three treatment groups (30 subjects/group) with daily dosages of 0 (placebo), 84 and 126 mg isoflavones for 6 months. Further inclusion criteria included body mass index <30 kg/m2 and Kuppermann Climacteric Scale >15. Bone mineral density (BMD) of the spine and hip were measured using dual- energy X-ray absorptiometry at 0 and 6 months. Serum osteocalcin, bone-specific alkaline phosphatase (BAP) and urinary deoxypyridinoline were examined at 0, 3 and 6 months.

Results

Mean percent changes in BMD at the lumbar spine (p = 0.114) and femoral neck (p = 0.053) increased with the supplementations of soy isoflavones after adjusting for age, years since menopause, body weight and height, dietary intakes of isoflavones, calcium and protein, physical activities and baseline BMD at the relevant sites. We observed significantly dose-dependent linear relationship between the supplemental isoflavones and percent changes of BMD at the spine (p = 0.042) and femoral neck (p = 0.016) post-treatment, and urinary total deoxypyridinoline (p = 0.014) at 12 weeks but not at 24 weeks after adjusting for the above factors. No significant difference in percent changes in serum osteocalcin (p > 0.05) and BAP (p > 0.05) was found among the three treatment groups at 12-week and 24-week post-treatment.

Conclusion

There is a significantly dose-dependent effect of soy isoflavones on attenuating bone loss at the spine and femoral neck possibly via the inhibition of bone resorption in non-obese postmenopausal Chinese women with high Kuppermann Scale.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wasnich RD (1997) Epidemiology of osteoporosis in the United States of America. Osteoporos Int Suppl 3:S68–S72

    Google Scholar 

  2. Ho SC, Lau EM, Woo J, Sham A, Chan KM, Lee S, Leung PC (1999) The prevalence of osteoporosis in the Hong Kong Chinese female population. Maturitas 32:171–178

    Article  CAS  Google Scholar 

  3. Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston CC, Kleerekoper M, Lindsay R, Luckey MM, McClung MR, Nankin HR, Petak SM, Recker RR (2001) American association of clinical endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 7:293–312

    CAS  Google Scholar 

  4. Xu H, Wu Y, Yan Y (1998) Preliminary study on bone loss rate in early and late stages of postmenopausal women. Chinese J Obstet Gynecol 33:542–545

    CAS  Google Scholar 

  5. Garg P, Kerlikowske K, Subak L, Grady D (1998) Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 92:472–479

    Article  CAS  Google Scholar 

  6. Murkies AL, Wilcox G, Davis SR (1998) Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab 83:297–303

    Article  CAS  Google Scholar 

  7. Greendale GA, FitzGerald G, Huang MH, Sternfeld B, Gold E, Seeman T, Sherman S, Sowers M (2002) Dietary soy isoflavones and bone mineral density: results from the study of women’s health across the nation. Am J Epidemiol 155:746–754

    Article  Google Scholar 

  8. Mei J, Yeung SS, Kung AW (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86:5217–5221

    Article  CAS  Google Scholar 

  9. Blum SC, Heaton SN, Bowman BM, Hegsted M, Miller SC (2003) Dietary soy protein maintains some indices of bone mineral density and bone formation in aged ovariectomized rats. J Nutr 133:1244–1249

    CAS  Google Scholar 

  10. Anderson JJ, Ambrose WW, Garner SC, Ohue T (2003) The effects of phytoestrogens on bone. Nutr Res 17:1617–1631

    Article  Google Scholar 

  11. Shi LN, Su YX (2000) The effect of soybean isoflavones on bone loss in ovariectomized rat. Acta Nutrimenta Sinica 22:113–118

    CAS  Google Scholar 

  12. Anderson JJ, Anthony M, Messina MJ, Garner SC (1999) Effects of phyto-oestrogens on tissues. Nutr Res Rev 12:75–116

    Article  CAS  Google Scholar 

  13. Anderson JJ, Ambrose WW, Garner SC (1998) Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model. Proc Soc Exp Biol Med 217:345–350

    CAS  Google Scholar 

  14. Arjmandi BH, Smith BJ (2002) Soy isoflavones’ osteoprotective role in postmenopausal women: mechanism of action. J Nutr Biochem 13:130–137

    Article  CAS  Google Scholar 

  15. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844–852

    CAS  Google Scholar 

  16. Anderson JJ, Chen X, Boass A, Symons M, Kohlmeier M, Renner JB, Garner SC (2002) Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year. J Am Coll Nutr 21:388–393

    CAS  Google Scholar 

  17. Chen YM, Ho SC, Lam SSH, Ho SSS, Woo JLF (2003) Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88:4740–4747

    Article  CAS  Google Scholar 

  18. Hsu CS, Shen WW, Hsueh YM, Yeh SL (2001) Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J Reprod Med 46:221–226

    CAS  Google Scholar 

  19. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68:1375S–1379S

    CAS  Google Scholar 

  20. Kreijkamp-Kaspers S, Kok L, Grobbee DE, Haan EHF, Aleman A, Lampe JW, Schouw YT (2004) Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA 292:65–74

    Article  CAS  Google Scholar 

  21. Setchell KD, Lydeking-Olsen E (2003) Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78:593S–609S

    CAS  Google Scholar 

  22. Wang HJ, Murphy PA (1994) Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666–1673

    Article  CAS  Google Scholar 

  23. Huang MH, Harrison GC, Mohamed MM, Gombein JA, Henning SM, Go VL, Greendale GA (2000) Assessing the accuracy of a food frequency questionnaire for estimating usual intake of phytoestrogens. Nutr Cancer 37:145–154

    Article  CAS  Google Scholar 

  24. Institute of Nutrition, Food Safety, China CDC (2002) China food composition 2002, 1st edn. Peking University Medical Press, Beijing, pp 24–219

    Google Scholar 

  25. Liu B, Woo J, Tang N, Ng K, Ip R, Yu A (2001) Assessment of total energy expenditure in a Chinese population by a physical activity questionnaire: examination of validity. Int J Food Sci Nutr 52:269–282

    Article  CAS  Google Scholar 

  26. Behr W, Barnert J (1986) Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility. Clin Chem 32:1960–1966

    CAS  Google Scholar 

  27. Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA (2004) The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 79(2):326–333

    CAS  Google Scholar 

  28. Ho SC, Chan SG, Yi Q, Wong E, Leung PC (2001) Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res 16:1363–1369

    Article  CAS  Google Scholar 

  29. Anderson JJ, Garner SC (1998) Phytoestrogens and bone. Baillieres Clin Endocrinol Metab 12:543–557

    Article  CAS  Google Scholar 

  30. Ho SC, Woo J, Lam SSH, Chen YM, Sham A, Lau J (2003) Soy protein consumption and bone mass in early postmenopausal Chinese women. Osteoporos Int 14:835–842

    Article  CAS  Google Scholar 

  31. Springfield IL, Charles C, Thomas H (1973) Remodeling as a determinant of envelope physiology. In: Frost HM (ed) Bone remodeling and its relationship to metabolic bone disease. Orthopedic Lectures 28–53

  32. Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, Wild RA (2003) Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 88:1048–1054

    Article  CAS  Google Scholar 

  33. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H (2000) Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 11:721–724

    Article  CAS  Google Scholar 

  34. Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, Kurzer M S (2000) Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85:3043–3048

    Article  CAS  Google Scholar 

  35. Barnes S (2003) Phyto-oestrogens and osteoporosis: what is a safe dose? Br J Nutr 89:S101–S108

    Article  CAS  Google Scholar 

  36. Chen YM, Ho SC, Lam SS, Ho SS, Woo JL (2004) Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause 11:246–254

    Article  Google Scholar 

  37. Zhao G, Wang L, Yan R, Dennerstein L (2000) Menopausal symptoms: experience of Chinese women. Climacteric 3:135–44

    Article  CAS  Google Scholar 

  38. Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81:397–408

    CAS  Google Scholar 

Download references

Acknowledgments

This study was jointly supported by Guangzhou Sciences and Technology Bureau (2002J1-C0081), and Acatris Holding B.V. The soy isoflavone extract was donated by Acatris Holding B.V., Giessen, The Netherlands.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yi-Xiang Su MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ye, YB., Tang, XY., Verbruggen, M. et al. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women. Eur J Nutr 45, 327–334 (2006). https://doi.org/10.1007/s00394-006-0602-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-006-0602-2

Keywords

Navigation